Phages Pharmaceutical Private Limited
About Phages Pharmaceutical Private Limited
Data last updated:
Phages Pharmaceutical Private Limited is a private limited company based in Prayagraj, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U85300UP2019PTC118354.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Shyam Sunder and Dhiraj Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 90F/10M Rajrooppur, Prayagraj, Uttar Pradesh, India – 211011.
As per the financials filed for FY 2024, the company reported a revenue of ₹42,360, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹2,818 (net margin 6.7%) and EBITDA of ₹11,000 (EBITDA margin 26%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years.
Company details
Contact details
Phages Pharmaceutical Private Limited's registered office is in Prayagraj, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address90F/10M Rajrooppur, Prayagraj, Uttar Pradesh, India – 211011
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Phages Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Phages Pharmaceutical Private Limited
FY 2025 filings availablePhages Pharmaceutical Private Limited reported revenue of ₹42,360 (up 20% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over three years, including 20% growth in the latest year. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,818 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26% | ||||
| Net Profit Margin | 6.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Phages Pharmaceutical Private Limited, buy the company report.
Board of directors of Phages Pharmaceutical Private Limited
Phages Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shyam Sunder | Director | 21 Jun 2019 | 7 Years 4 Months | Current |
| Dhiraj Agrawal Also directs: Linqr Corporation Private Limited | Director | 09 Oct 2021 | 5 Years 0 Months | Current |
Auditor
Phages Pharmaceutical Private Limited is audited by HISARIA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HISARIA & ASSOCIATES | FY 2021 | 023697C |
Shareholding
The shareholding of Phages Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Phages Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Phages Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Phages Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Phages Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Phages Pharmaceutical Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Dhiraj Agrawal was appointed as Director on 09 Oct 2021.
Frequently asked questions
Phages Pharmaceutical is an active private limited company based in Prayagraj, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 June 2019 (7+ years old) and is registered under CIN U85300UP2019PTC118354.
Phages Pharmaceutical has 2 current directors:
- Shyam Sunder - Director
- Dhiraj Agrawal - Director
The latest financial statements of Phages Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Phages Pharmaceutical is U85300UP2019PTC118354. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Phages Pharmaceutical was incorporated on 21 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
Dhiraj Agrawal was appointed as Director on 09 Oct 2021. Purushottam Agrawal ceased to be Director on 09 Oct 2021. Shyam Sunder was appointed as Director on 21 Jun 2019.
The registered office of Phages Pharmaceutical is at 90F10M Rajrooppur, Prayagraj, Uttar Pradesh, India – 211011.
Phages Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
Phages Pharmaceutical can be reached at its registered office: 90F10M Rajrooppur, Prayagraj, Uttar Pradesh, India – 211011.
Phages Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.